The role of adapter protein Shc in estrogen non-genomic action

[1]  P. Kang,et al.  Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice , 2002, Molecular and Cellular Biology.

[2]  K. Korach,et al.  Estradiol (E2) elicits SRC phosphorylation in the mouse neocortex: the initial event in E2 activation of the MAPK cascade? , 2001, Endocrinology.

[3]  A. Bilancio,et al.  PI3‐kinase in concert with Src promotes the S‐phase entry of oestradiol‐stimulated MCF‐7 cells , 2001, The EMBO journal.

[4]  Kodi S Ravichandran,et al.  Signaling via Shc family adapter proteins , 2001, Oncogene.

[5]  D. Márquez,et al.  Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells , 2001, Oncogene.

[6]  J E Paciga,et al.  Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. , 2001, Cancer research.

[7]  D. Edwards,et al.  Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. , 2001, Molecular cell.

[8]  M. J. Fry.  Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play? , 2001, Breast Cancer Research.

[9]  B. Katzenellenbogen,et al.  Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Dissociation from Transcriptional Activity , 2001, Cell.

[10]  B. Katzenellenbogen,et al.  Estrogen receptors: selective ligands, partners, and distinctive pharmacology. , 2000, Recent progress in hormone research.

[11]  K. Bland,et al.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. , 2000, Molecular endocrinology.

[12]  K. Ley,et al.  Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase , 2000, Nature.

[13]  E. Levin,et al.  Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. , 2000, Molecular endocrinology.

[14]  M. van Eickels,et al.  Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway* , 2000, The Journal of Biological Chemistry.

[15]  C. Breton,et al.  Estradiol-stimulated nitric oxide release in human granulocytes is dependent on intracellular calcium transients: evidence of a cell surface estrogen receptor , 2000 .

[16]  P. Gruppuso,et al.  The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes. , 2000, Molecular endocrinology.

[17]  G. Fricchione,et al.  Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. , 2000, Circulation.

[18]  C. Watson,et al.  Antibodies to the estrogen receptor‐α modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  M. Waterfield,et al.  Signaling by distinct classes of phosphoinositide 3-kinases. , 1999, Experimental cell research.

[20]  Pier Paolo Pandolfi,et al.  The p66shc adaptor protein controls oxidative stress response and life span in mammals , 1999, Nature.

[21]  J. York,et al.  Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Pappas,et al.  Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α , 1999, Steroids.

[23]  J. Mendelsohn,et al.  Heregulin Regulates Cytoskeletal Reorganization and Cell Migration through the p21-activated Kinase-1 via Phosphatidylinositol-3 Kinase* , 1998, The Journal of Biological Chemistry.

[24]  Wen-rong Gong,et al.  Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross‐talk with estrogen receptor , 1998, The EMBO journal.

[25]  P. Pandolfi,et al.  A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. , 1996, Oncogene.

[26]  P. Bontempo,et al.  Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells. , 1996, The EMBO journal.

[27]  B. Katzenellenbogen,et al.  Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. , 1996, Molecular endocrinology.

[28]  B. Lamothe,et al.  Interaction of p85 subunit of PI 3‐kinase with insulin and IGF‐1 receptors analysed by using the two‐hybrid system , 1995, FEBS letters.

[29]  M. Borrello,et al.  Constitutive phosphorylation of Shc proteins in human tumors. , 1995, Oncogene.

[30]  G. Superti-Furga.  Regulation of the Src protein tyrosine kinase , 1995, FEBS letters.

[31]  Giulio Superti‐Furga,et al.  Structure‐function relationships in Src family and related protein tyrosine kinases , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[32]  E. Lapetina,et al.  Insulin-like growth factor-1-mediated association of p85 phosphatidylinositol 3-kinase with pp 185: requirement of SH2 domains for in vivo interaction. , 1994, Molecular endocrinology.

[33]  C. Gay,et al.  Specific binding of estrogen to osteoclast surfaces. , 1994, Biochemical and biophysical research communications.

[34]  Sheila M. Thomas,et al.  Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases , 1992, Nature.

[35]  P. Chambon,et al.  Cooperation of proto‐signals for nuclear accumulation of estrogen and progesterone receptors. , 1992, The EMBO journal.

[36]  E. Lapetina,et al.  Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85. , 1992, The Journal of biological chemistry.

[37]  P. Pagésy,et al.  Evidence for a specific estradiol binding site on rat pituitary membranes. , 1986, Endocrinology.

[38]  C. Watson.  The Identities of Membrane Steroid Receptors , 2003, Springer US.

[39]  R. Santen,et al.  Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. , 2002, Molecular endocrinology.

[40]  M. Waterfield,et al.  Synthesis and function of 3-phosphorylated inositol lipids. , 2001, Annual review of biochemistry.

[41]  S. Hubbard,et al.  Protein tyrosine kinase structure and function. , 2000, Annual review of biochemistry.